Patient derived renal cell carcinoma xenografts exhibit distinct sensitivity patterns in response to antiangiogenic therapy and constitute a suitable tool for biomarker development

Systemic treatment is necessary for one third of patients with renal cell carcinoma. No valid biomarker is currently available to tailor personalized therapy. In this study we established a representative panel of patient derived xenograft (PDX) mouse models from patients with renal cell carcinomas...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Oncotarget
Main Authors: Schueler, Julia, Klingner, Kerstin, Bug, Daniel, Zoeller, Caren, Maier, Armin, Dong, Meng, Willecke, Kerstin, Peille, Anne-Lise, Steiner, Eva, Landesfeind, Manuel, Copland, John A., Siegers, Gabrielle M., Haferkamp, Axel, Boehm, Katharina, Tsaur, Igor, Schneider, Meike
פורמט: Artigo
שפה:Inglês
יצא לאור: Impact Journals LLC 2018
נושאים:
Research Paper
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6089561/
https://ncbi.nlm.nih.gov/pubmed/30123419
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25697
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים